| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Nov 25, 2025 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 90.0 | +1,509 | 8.64% | ✗ | $62.8K |
| Sep 4, 2025 | Sep 8, 2025 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 28.8 | -1,721 | -8.97% | ✓ | $57.7K |
| Sep 2, 2025 | Sep 4, 2025 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 45.0 | -485 | -2.47% | ✓ | $14.6K |
| Aug 19, 2025 | Aug 21, 2025 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 46.3 | -725 | -3.56% | ✗ | $19.3K |
| May 19, 2025 | May 21, 2025 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 47.5 | -10,712 | -3.38% | ✗ | $7.2K |
| Feb 19, 2025 | Feb 21, 2025 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 46.3 | -10,300 | -3.15% | ✗ | $10.4K |
| Dec 19, 2024 | Dec 20, 2024 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 46.3 | -51,115 | -13.52% | ✗ | $48K |
| Nov 19, 2024 | Nov 20, 2024 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 47.5 | -7,785 | -3.10% | ✗ | $7.9K |
| Aug 19, 2024 | Aug 20, 2024 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 47.5 | -6,866 | -2.66% | ✗ | $8.8K |
| May 17, 2024 | May 20, 2024 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 46.3 | -7,355 | -2.78% | ✗ | $12.9K |
| Feb 20, 2024 | Feb 22, 2024 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 47.5 | -9,014 | -3.29% | ✗ | $6.1K |
| Nov 17, 2023 | Nov 20, 2023 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 47.5 | -9,646 | -3.40% | ✗ | $4.7K |
| Aug 16, 2023 | Aug 17, 2023 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 47.5 | -9,703 | -3.31% | ✗ | $7.6K |
| May 16, 2023 | May 17, 2023 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 47.5 | -9,791 | -3.23% | ✗ | $7K |
| Feb 16, 2023 | Feb 17, 2023 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 46.3 | -10,484 | -3.34% | ✗ | $31.5K |
| Nov 16, 2022 | Nov 18, 2022 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 46.3 | -13,460 | -4.11% | ✗ | $48.1K |
| Aug 18, 2022 | Aug 19, 2022 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 17.5 | -73,716 | -18.39% | ✓ | $342.8K |
| Aug 15, 2022 | Aug 17, 2022 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 95.0 | +124,440 | 45.02% | ✗ | $50.3K |
| May 15, 2022 | May 17, 2022 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 72.5 | +2,277 | 0.83% | ✗ | $85.6K |
| Feb 16, 2022 | Feb 18, 2022 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 42.5 | -10,912 | -3.83% | ✗ | $119.5K |
| Nov 15, 2021 | Nov 17, 2021 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 92.5 | +19,281 | 9.06% | ✗ | $274.6K |
| Aug 16, 2021 | Aug 18, 2021 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 42.5 | -7,662 | -3.48% | ✗ | $106K |
| May 17, 2021 | May 19, 2021 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 40.0 | -31,111 | -11.69% | ✗ | $569.3K |
| Feb 16, 2021 | Feb 18, 2021 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 40.0 | -24,141 | -8.32% | ✗ | $540K |
| Nov 23, 2020 | Nov 25, 2020 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 30.0 | -16,380 | -6.14% | ✓ | $268.6K |
| Nov 16, 2020 | Nov 18, 2020 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 40.0 | -29,618 | -10.00% | ✗ | $501.4K |
| Aug 17, 2020 | Aug 19, 2020 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 40.0 | -26,200 | -8.12% | ✗ | $515.4K |
| May 18, 2020 | May 20, 2020 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 42.5 | -4,558 | -1.39% | ✗ | $102.6K |
| Feb 18, 2020 | Feb 20, 2020 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 42.5 | -4,774 | -1.44% | ✗ | $106.7K |
| Nov 18, 2019 | Nov 20, 2019 | NEKTAR THERAPEUTICS | Chief R&D Officer | Sell | 42.5 | -3,960 | -1.34% | ✗ | $71.2K |